Definitive Contract W91YTZ21C0006
- Not listed
- This federal contract award is for the provision of blood donor testing services to support the Defense Health Agency. The prime contractor, Qualtex Laboratories, is a subsidiary of the non-profit organization Biobridge Global. The contract, valued at $4,534,464.50, has an ultimate completion date of September 30, 2025. Qualtex Laboratories will provide specialized laboratory services related to blood and tissue screening, donor testing, and transfusion medicine in support of military medical...
- This is a $570,975.00 firm-fixed-price purchase order contract awarded by the U.S. Army Medical Command (MEDCOM) to Qualtex Laboratories, a subsidiary of the nonprofit organization Biobridge Global. The contract is for the provision of specialized laboratory services related to blood and tissue screening, donor testing, and transfusion medicine to support military medical facilities and operations. There was no set-aside designation on this contract award. Qualtex Laboratories has a history of...
- The Defense Health Agency awarded a $102,355.98 firm-fixed-price purchase order to Qualtex Laboratories, a subsidiary of the nonprofit Biobridge Global, to provide testing for transfusion-transmissible diseases in blood samples. The contract, which does not have a set-aside designation, calls for services to be performed in Silver Spring, Maryland, with a completion date of May 26, 2026. Qualtex Laboratories is an experienced federal contractor, having received prior prime contracts from the...
- This is a definitive contract awarded by the U.S. Army Medical Command (MEDCOM) to Qualtex Laboratories, a subsidiary of the non-profit organization Biobridge Global. The contract, valued at $9,601,854.07, is for whole blood test panel and confirmatory test services to be provided at U.S. Army installations Fort Benning and Fort Gordon. The contract has a firm fixed price pricing type and a completion date of September 30, 2021. There was no set-aside designation used for this award. Qualtex...
- This is a firm-fixed-price purchase order contract awarded by the Defense Health Agency (DHA) to Qualtex Laboratories, a subsidiary of Biobridge Global, a non-profit organization. The contract is for $1,975,912.54 and provides blood donor testing services to support the Armed Services Blood Bank Center - Europe located at Landstuhl Regional Medical Center in Germany. The services include standard and confirmatory testing for reportable infectious diseases in blood donations, in accordance with...
- This is a $26,386.52 firm-fixed-price purchase order awarded by the Defense Health Agency (DHA) to Qualtex Laboratories, a non-profit subsidiary of Biobridge Global. The contract is for commercial laboratory services to perform testing on malaria-infected blood samples from human subjects received from overseas field sites, in support of the Walter Reed Army Institute of Research (WRAIR). This contract does not have a set-aside designation. Qualtex Laboratories has previously received prime...
- This is a firm fixed-price purchase order contract awarded by the Department of the Army Medical Command to Qualtex Laboratories, a subsidiary of the nonprofit organization Biobridge Global. The contract, valued at $172,329.37, is for Zika infectious disease testing services. Qualtex provides specialized laboratory services related to blood and tissue screening, donor testing, and transfusion medicine to support military medical facilities and operations, both domestically and overseas. The...
- This is a $188,028.52 firm-fixed-price purchase order contract awarded by the U.S. Army Medical Command (MEDCOM) to Qualtex Laboratories, a subsidiary of the non-profit organization Biobridge Global. The contract is for reportable test services related to Zika virus testing. No set-aside was used for this award. Qualtex Laboratories specializes in providing laboratory services to support the healthcare needs of military personnel and veterans, including blood and tissue screening, donor testing,...
- This is a firm fixed-price purchase order awarded by the Defense Health Agency (DHA) to Creative Testing Solutions, a non-profit organization based in Tempe, Arizona. The $4,332,565.36 contract is for blood donor testing services at two Army medical facilities in Texas and Missouri. The contract has an ultimate completion date of September 30, 2025 and does not utilize a small business set-aside. The contract is a follow-on to a previous award held by Creative Testing Solutions, and the services...
- This is a $4,914,300.00 firm-fixed-price delivery order contract awarded by the Defense Health Agency (DHA) to Center For Disease Detection, LLC, a subsidiary of Laboratory Corporation of America Holdings. The contract is for the provision of medical laboratory testing services to detect antigens and antibodies of Human Immunodeficiency Virus (HIV), Hepatitis B Surface Antibody (HBsAb), Hepatitis B Surface Antigen (HBsAg), and Hepatitis C Virus (anti-HCV) for the U.S. military. The contract...
This is a $3,948,537.18 firm-fixed-price definitive contract awarded by the Defense Health Agency to Qualtex Laboratories, a subsidiary of the non-profit organization Biobridge Global. The contract is for blood testing services, including whole blood testing, cytomegalovirus testing, low titer whole blood/plasma testing, and reference laboratory testing. The contract has a base period from April 2021 through September 2021 with four one-year option periods extending through September 2025. This contract was awarded under a competitive solicitation that did not have a set-aside designation. Qualtex Laboratories and its parent Biobridge Global have a history of providing specialized laboratory services to support military medical facilities and operations, both domestically and overseas, through federal contracts with various defense agencies.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Blood Donor Laboratory Testing | W91YTZ-21-R-0002 | Department of the Army Medical Command | Solicitation 1/1 | 1/21/21, 2:46 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00017 | Funding Only Action | ($100k) | 7/8/25 | |
| P00016 | Funding Only Action | ($350k) | 3/26/25 | |
| P00015 | Funding Only Action | ($286k) | 2/14/25 | |
| P00014 | Funding Only Action | $1.3m | 10/31/24 | |
| P00013 | Exercise an Option | $0 | 7/24/24 |